In addition, the role of DUSP16 in the response of cancers to chemotherapeutic agents identified in this study suggests that DUSP16 could be a marker for predicting the efficacy of chemotherapy, and also a target for the development of therapies to improve treatment efficacy. This evidence concerns the gene DUSP16 and cancer.